FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093080 [Registered on: 14/08/2025] Trial Registered Prospectively
Last Modified On: 13/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   EFFECT OF SAHACHAR, NIMB, PATHA, PATOL KWATH YONI DHAWAN IN KAPHAJ YONI VYAPAD. 
Scientific Title of Study   "RANDOMIZED CONTROLLED CLINICAL TRIAL TP STUDY THE EFFICACY OF SAHACHAR, NIMB, PATHA, PATOL KWATH YONIDHAWAN IN THE MANAGEMENT OF KAPHAJ YONIVYAPAD" 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shubhangi Gajanan Mulange 
Designation  PG Scholar 
Affiliation  Ayurvedic Medical College and Hospital PG Institue And Reserch Center Uran Islampur Sangli 
Address  LRP Ayurvedic Medical College and Hospital PG Institue And Reserch Center Uran Islampur Sangli
OPD No 5 Prasutitantra And Streerog Department LRP Ayurvedic Medical College and Hospital PG Institue And Reserch Center Uran Islampur Sangli, Maharashtra 415409.
Sangli
MAHARASHTRA
415409
India 
Phone  7249339564  
Fax    
Email  shubhangimulange09@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sachin Jagannath Patil 
Designation  Professor 
Affiliation  Ayurvedic Medical College and Hospital PG Institue And Reserch Center Uran Islampur Sangli 
Address  LRP Ayurvedic Medical College and Hospital PG Institue And Reserch Center Uran Islampur Sangli
OPD No 5 Prasutitantra And Streerog Department LRP Ayurvedic Medical College and Hospital PG Institue And Reserch Center Uran Islampur Sangli, Maharashtra 415409.
Sangli
MAHARASHTRA
415409
India 
Phone  9422407301  
Fax    
Email  Sachinpatil5190@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sachin Jagannath Patil 
Designation  Professor 
Affiliation  Ayurvedic Medical College and Hospital PG Institue And Reserch Center Uran Islampur Sangli 
Address  LRP Ayurvedic Medical College and Hospital PG Institue And Reserch Center Uran Islampur Sangli
OPD No 5 Prasutitantra And Streerog Department LRP Ayurvedic Medical College and Hospital PG Institue And Reserch Center Uran Islampur Sangli, Maharashtra 415409.
Sangli
MAHARASHTRA
415409
India 
Phone  9422407301  
Fax    
Email  Sachinpatil5190@gmail.com  
 
Source of Monetary or Material Support  
Loknete Rajarambapu Patil Ayurvedic Medical College and Hospital PG Institute And Research Centre Urun Islampur Sangli Maharashtra India 415409. 
 
Primary Sponsor  
Name  DrShubhangi Gajanan Mulange 
Address  Loknete Rajarambapu Patil Ayurvedic Medical College and Hospital PG Institute And Reserch Center Urun Islampur Sangli Maharashtra India 415409 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shubhangi Gajanan Mulange  LRP Ayurvedic Medical College and Hospital PG Institue And Reserch Center Uran Islampur Sangli  OPD No 5 Department Of Streerog And Prasutitantra LRP Ayurvedic Medical College And Research Institute Urun Islampur Sangli Maharashtra
Sangli
MAHARASHTRA 
7249339564

shubhangimulange09@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee LRP Ayurvedic Medical College and Hospital and PTC and RC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:1||Obstetrics. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: SAHACHAR NIMB PATHA PATOL KWATH, Reference: ASHTANG HRUDAYA UTTARTANTRA, Route: Vaginal, Dosage Form: Kwatha/ Kashaya, Dose: 1000(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -7 DAYS FOR 1 CYCLE
2Comparator ArmDrugClassical(1) Medicine Name: TRIPHALA KWATH, Reference: ASHTANG SANGRAHA UTTARTANTRA, Route: Vaginal, Dosage Form: Kwatha/ Kashaya, Dose: 1000(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -7 DAYS FOR 1 CYCLE
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  1. Married women of Age between 20-45 Years
2. Shweta strav
3. Kandu
4. Alpavedana 
 
ExclusionCriteria 
Details  1. Pregnant Women
2. Patients with Diabetes, Sexually Transmitted Disease, HIV,
Gonorrhea, malignancies, Carcinoma of cervix, Pelvic
Inflammatory Disease, IUCD, patient on
3. Patient not willing to give informed consent
4. Unexplained vaginal bleeding — occasionally and
intermitted. 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Decreased In Yonigat Strava, Yonigat Kandu, Yonigat Vedana.  7 days 
 
Secondary Outcome  
Outcome  TimePoints 
Significant Decreased In Signs and Symptoms Yonigat Strava, Yonigat Kandu, Yonigat Vedana.  1 month 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   24/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Need has always been felt to develop certain Ayurvedic treatment modalities for 
the management of Kaphaj Yonivyapad and vaginal candidiasis which could be safe, 
effective, readily available, cost effective, without any side effects in comparison to 
the therapeutic procedures of different systems of medicine. There is Need to maintain womens health for this Sahachara, Nimb, Patha, Patol 
kwath are used they have properties like Kaphashamak, Kandughana, Krimighana,
Stambhak, Vranaropak, Antiseptic. Because of these properties it helps to overcome 
the symptoms of Kaphaj Yonivyapad it may increase local immunity there by prevent 
recurrence of symptoms in patients. In other pathy drug generally have minor, major side effect it may be due to 
prolong use of that drug but, in ayurvedic formulation has minimum side effects. 
hence selection of appropriate treatment without disturbing other systems are used.
 
Close